| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Sep'16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total revenues | |||||||||||||
7,062 | 11,081 | 12,397 | 6,677 | 4,476 | 3,024 | 1,902 | 1,274 | 865 | - | 0 | 0 | - | - |
Gross margin | |||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - |
Licensing revenues | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Costs and expenses: | |||||||||||||
Cost of product sales | |||||||||||||
1,356 | - | - | - | 738 | - | - | - | - | - | - | - | - | - |
Net product revenues | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 | - |
Cost of product sales | |||||||||||||
- | - | 1,389 | 1,089 | - | 718 | 319 | 351 | 200 | 0 | 0 | 0 | 0 | - |
Research and development | |||||||||||||
4,932 | 5,379 | 5,547 | 5,295 | 4,562 | 3,363 | 2,989 | 2,046 | 1,701 | 1,212 | 6,641 | 4,749 | 4,230 | 3,868 |
Selling, general and administrative | |||||||||||||
27,060 | 26,545 | 25,270 | 26,000 | 26,340 | 23,661 | 22,086 | 21,860 | 28,011 | 18,484 | 6,553 | 3,588 | 3,073 | 1,761 |
Total operating expenses | |||||||||||||
33,348 | - | 32,206 | 32,384 | 31,640 | - | 25,394 | 24,257 | 29,912 | 19,696 | 13,194 | 8,337 | 7,303 | 5,629 |
Loss from operations | |||||||||||||
-26,286 | -22,921 | -19,809 | -25,707 | -27,164 | -24,718 | -23,492 | -22,983 | -29,047 | -19,696 | -13,194 | -8,337 | -7,303 | -5,629 |
Other (income) expense: | |||||||||||||
Grant and other income | |||||||||||||
- | - | 0 | 0 | - | 30 | 42 | 145 | 189 | - | - | - | - | - |
Grant and other income | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 49 | 370 |
Interest income | |||||||||||||
332 | 400 | 559 | 716 | 684 | 715 | 680 | 582 | 476 | 147 | 61 | 60 | 35 | 38 |
Interest expense | |||||||||||||
2,863 | 2,474 | 2,372 | 2,389 | 2,388 | 2,374 | 2,361 | 2,301 | 2,193 | 48 | 0 | 0 | 862 | 885 |
Foreign currency losses | |||||||||||||
-39 | 1 | -31 | 3 | -6 | -35 | 8 | -24 | 3 | 7 | 35 | 25 | 6 | 0 |
Loss on extinguishment of debt | |||||||||||||
- | - | -7,155 | - | - | - | 0 | - | - | - | - | - | - | - |
Net loss | |||||||||||||
-28,856 | -24,994 | -28,808 | -27,377 | -28,874 | -26,382 | -25,123 | -24,581 | -30,572 | -19,551 | -13,068 | -8,208 | -8,075 | -6,106 |
Net loss per share of common stock, basic and diluted (in USD per share) | |||||||||||||
-0.63 | -0.58 | -0.69 | -0.66 | -0.70 | -0.62 | -0.61 | -0.64 | -0.81 | - | - | - | - | - |
Weighted average common shares outstanding, basic and diluted (in shares) | |||||||||||||
45,906 | 43,489 | 41,454 | 41,310 | 41,256 | 41,319 | 41,207 | 38,688 | 37,849 | - | - | - | - | - |
Deemed dividend | |||||||||||||
- | - | - | - | - | - | - | - | - | 714 | 4,105 | 4,083 | 3,067 | 2,752 |
Accretion to redemption value | |||||||||||||
- | - | - | - | - | - | - | - | - | 3 | 19 | 546 | 528 | 527 |
Net loss attributable to common stockholders | |||||||||||||
- | - | - | - | - | - | - | - | - | -20,268 | -17,192 | -12,837 | -11,670 | -9,385 |
basic (in USD per share) | |||||||||||||
- | - | - | - | - | - | - | - | - | 4.63 | -4.23 | -3.16 | -2.87 | -2.32 |
diluted (in USD per share) | |||||||||||||
- | - | - | - | - | - | - | - | - | 4.63 | -4.23 | -3.16 | -2.87 | -2.32 |
basic (in shares) | |||||||||||||
- | - | - | - | - | - | - | - | - | 31,793 | 4,067 | 4,067 | 4,067 | - |
diluted (in shares) | |||||||||||||
- | - | - | - | - | - | - | - | - | 31,793 | 4,067 | 4,067 | 4,067 | 4,050 |
Net product revenues | |||||||||||||
Total revenues | |||||||||||||
7,062 | 11,081 | 8,667 | 6,677 | 3,976 | 3,024 | 1,902 | 1,274 | 865 | - | - | - | - | - |
Licensing revenues | |||||||||||||
Total revenues | |||||||||||||
0 | 0 | 3,730 | 0 | 500 | 0 | 0 | 0 | 0 | - | - | - | - | - |